SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 84 filers reported holding SEELOS THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $57 | -19.7% | 48,018 | -54.3% | 0.01% | -33.3% |
| Q4 2022 | $71 | -99.9% | 105,050 | -23.5% | 0.01% | -52.6% |
| Q3 2022 | $141,000 | +642.1% | 137,266 | +398.4% | 0.02% | +533.3% |
| Q2 2022 | $19,000 | -90.3% | 27,541 | -66.0% | 0.00% | -85.0% |
| Q3 2021 | $195,000 | +387.5% | 80,998 | +216.9% | 0.02% | +185.7% |
| Q4 2020 | $40,000 | +53.8% | 25,557 | -6.9% | 0.01% | +75.0% |
| Q3 2020 | $26,000 | – | 27,437 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,500,000 | $4,075,000 | 1.71% |
| Connacht Asset Management LP | 498,925 | $813,000 | 0.79% |
| GENDELL JEFFREY L | 2,449,267 | $3,992,000 | 0.32% |
| MANGROVE PARTNERS IM, LLC | 2,133,436 | $3,478,000 | 0.21% |
| Uniplan Investment Counsel, Inc. | 1,550,359 | $2,527,000 | 0.14% |
| Financial Advocates Investment Management | 24,673 | $1,994,000 | 0.13% |
| Connacht Asset Management LP | 72,300 | $118,000 | 0.12% |
| Woodline Partners LP | 4,047,231 | $6,597,000 | 0.09% |
| 1492 Capital Management LLC | 108,286 | $177,000 | 0.09% |
| Ikarian Capital, LLC | 244,171 | $398,000 | 0.06% |